Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: Implications for signaling

Molecular Cell

Volumn 14, Issue 3, 2004, Pages 405-412

  Shiozaki, Eric N ^a   Gu, Lichuan ^a   Yan, Nieng ^a   Shi, Yigong ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; BACH1 PHOSPHOPEPTIDE; BRCA1 PROTEIN; PEPTIDE; PHENYLALANINE; PHOSPHOPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CRYSTAL STRUCTURE; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HUMAN; MISSENSE MUTATION; MOLECULAR EVOLUTION; MUTAGENESIS; NUCLEOTIDE REPEAT; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 2342484423     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00238-2     Document Type: Article

References (38)

1. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:1997;68-76
2. Caldecott K.W. Cell signaling. The BRCT domain. signaling with friends? Science. 302:2003;579-580
3. Callebaut I., Mornon J.P. From BRCA1 to RAP1. a widespread BRCT module closely associated with DNA repair FEBS Lett. 400:1997;25-30
4. Cantor S., Drapkin R., Zhang F., Lin Y., Han J., Pamidi S., Livingston D.M. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. USA. 101:2004;2357-2362
5. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., Wahrer D.C., Sgroi D.C., Lane W.S., Haber D.A., et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell. 105:2001;149-160
6. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex. understanding tumorigenic mutations Science. 265:1994;346-355
7. Cortez D., Wang Y., Qin J., Elledge S.J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1100-1102
8. Dulic A., Bates P.A., Zhang X., Martin S.R., Freemont P.S., Lindahl T., Barnes D.E. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III. Biochemistry. 40:2001;5906-5913
9. Easton D.F., Bishop D.T., Ford D., Crockford G.P. Genetic linkage analysis in familial breast and ovarian cancer. results from 214 families. The Breast Cancer Linkage Consortium Am. J. Hum. Genet. 52:1993;678-701
10. Friedman L.S., Ostermeyer E.A., Szabo C.I., Dowd P., Lynch E.D., Rowell S.E., King M.C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet. 8:1994;399-404
11. Futreal P.A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L.M., Haugen-Strano A., Swensen J., Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 266:1994;120-122
12. Gayther S.A., Harrington P., Russell P., Kharkevich G., Garkavtseva R.F., Ponder B.A. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. Am. J. Hum. Genet. 58:1996;451-456
13. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956
14. Iwabuchi K., Bartel P.L., Li B., Marraccino R., Fields S. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA. 91:1994;6098-6102
15. Jones T.A., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119
16. Joo W.S., Jeffrey P.D., Cantor S.B., Finnin M.S., Livingston D.M., Pavletich N.P. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16:2002;583-593
17. Koonin E.V., Altschul S.F., Bork P. BRCA1 protein products. Functional motifs. Nat. Genet. 13:1996;266-268
18. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950
19. Liu K., Lin F.T., Ruppert J.M., Lin W.C. Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol. Cell. Biol. 23:2003;3287-3304
20. Lou Z., Minter-Dykhouse K., Wu X., Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 421:2003;957-961
21. Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 302:2003;636-639
22. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W. A strong candidate for the breast and overian cancer susceptibility gene BRCA1. Science. 266:1994;66-71
23. Navaza J. AMoRe and automated package for molecular replacement. Acta Crystallogr. A. 50:1994;157-163
24. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins: Struct Funct Genet. 11:1991;281-296
25. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326
26. Rodriguez M., Yu X., Chen J., Songyang Z. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278:2003;52914-52918
27. Scully R., Livingston D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 408:2000;429-432
28. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435. a
29. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley T., Livingston D.M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 88:1997;265-275. b
30. Scully R., Ganesan S., Vlasakova K., Chen J., Socolovsky M., Livingston D.M. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell. 4:1999;1093-1099
31. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966
32. Terwilliger T.C., Berendzen J. Correlated phasing of multiple isomorphous replacement data. Acta Crystallogr. D. 52:1996;749-757
33. Welcsh P.L., King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10:2001;605-713
34. Williams R.S., Green R., Glover J.N. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8:2001;838-842
35. Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bowcock A.M., Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:1996;430-440
36. Wu J.W., Hu M., Chai J., Seoane J., Huse M., Li C., Rigotti D.J., Kyin S., Muir T.W., Fairman R., et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell. 8:2001;1277-1289
37. Yaffe M.B., Elia A.E. Phosphoserine/threonine-binding domains. Curr. Opin. Cell Biol. 13:2001;131-138
38. Yu X., Chini C.C., He M., Mer G., Chen J. The BRCT domain is a phospho-protein binding domain. Science. 302:2003;639-642